• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Convey Announces Closing of Acquisition by TPG

    10/7/22 8:30:00 AM ET
    $CNVY
    Retail: Computer Software & Peripheral Equipment
    Technology
    Get the next $CNVY alert in real time by email

    Convey Taken Private by TPG for $10.50 per Share in Cash

    FORT LAUDERDALE, Fla., Oct. 7, 2022 /PRNewswire/ -- Convey Health Solutions Holdings, Inc. (NYSE:CNVY) ("Convey"), a leading healthcare technology and services company, announced today the closing of its acquisition by TPG Capital, the large-scale U.S. and European private equity platform of alternative asset management firm TPG.

    (PRNewsfoto/Convey Health Solutions)

    On June 21, 2022, Convey announced that TPG Capital had signed a definitive agreement to acquire all of the outstanding shares of Convey common stock not currently owned by TPG or certain management and director shareholders for $10.50 per share in cash, representing an enterprise value of approximately $1.1 billion.

    "We look forward to continuing our partnership with TPG as we work together to serve Convey's health plan clients and their members with our best-in-class technology platforms and business process solutions," said Stephen Farrell, CEO of Convey.

    Effective as of the closing of the transaction, trading of Convey's common stock has been suspended on the New York Stock Exchange (the "NYSE") and Convey has requested that its common stock be delisted from the NYSE.

    Davis Polk & Wardwell LLP acted as legal counsel to TPG. Centerview Partners acted as financial advisor to the Special Committee of the Board of Directors of Convey and Simpson Thacher & Bartlett LLP acted as its legal counsel. Cravath, Swaine & Moore LLP acted as legal counsel to Convey.

    About Convey

    Convey is a specialized healthcare technology and services company that is committed to providing clients with healthcare-specific, compliant member support solutions utilizing technology, engagement, and analytics. Convey's administrative solutions for government-sponsored health plans help to optimize member interactions, ensure compliance, and support end-to-end Medicare processes. By combining its best-in-class, built-for-purpose technology platforms with dedicated and flexible business process solutions, Convey creates better business results and better healthcare consumer experiences on behalf of business customers and partners. Convey's clients include some of the nation's leading health insurance plans and pharmacy benefit management firms. Their healthcare-focused teams help several million Americans each year to navigate the complex Medicare Advantage and Part D landscape. To learn more about Convey, please visit www.ConveyHealthSolutions.com.

    About TPG

    TPG is a leading global alternative asset management firm founded in San Francisco in 1992 with $127 billion of assets under management and investment and operational teams in 12 offices globally. TPG invests across five multi-product platforms: Capital, Growth, Impact, Real Estate, and Market Solutions and our unique strategy is driven by collaboration, innovation, and inclusion. Our teams combine deep product and sector experience with broad capabilities and expertise to develop differentiated insights and add value for our fund investors, portfolio companies, management teams, and communities. For more information, visit www.tpg.com or @TPG on Twitter.

    Cautionary Statement Regarding Forward-Looking Statements

    Certain statements in this communication may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements, which are based on current expectations, estimates and projections about the industry and markets in which TPG and Convey operate and beliefs of and assumptions made by TPG management and Convey management, involve uncertainties that could significantly affect the financial condition, results of operations, business plans and the future performance of TPG, Convey or the combined company. Words such as "approximately," "anticipate," "assume," "believe," "contemplate," "continue," "could," "estimate," "expect," "future," "intend," "may," "plan," "potential," "predict," "project," "seek," "should," "target," "will" and similar terms and phrases are intended to identify forward-looking statements but are not the exclusive means of identifying these statements. All of our forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those that we are expecting, including, among others:

    • the outcome of any legal proceedings regarding the transaction;
    • failure to retain key management and employees of Convey;
    • issues or delays in the successful integration of Convey's operations with those of Commodore Parent 2022, LLC, including incurring or experiencing unanticipated costs and/or delays or difficulties;
    • unfavorable reaction to the merger by customers, competitors, suppliers and employees;
    • unpredictability and severity of catastrophic events, including but not limited to acts of terrorism, war or hostilities or the COVID-19 pandemic, as well as management's response to any of the aforementioned factors; and
    • additional factors discussed in Convey's filings with the SEC.

    The forward-looking statements contained in this communication are based on management's current plans, estimates and expectations in light of information currently available to Convey and are subject to uncertainty and changes in circumstances. There can be no assurance that future developments affecting Convey will be those that Convey has anticipated. Actual results may differ materially from these expectations due to changes in global, regional or local political, economic, business, competitive, market, regulatory and other factors, many of which are beyond our control, as well as the other factors described in Item 1A, "Risk Factors" in Convey's 2021 10-K filed with the SEC on March 23, 2022, as supplemented in Item 1A. "Risk Factors" of Convey's Quarterly Report on Form 10-Q filed with the SEC on August 12, 2022. Should one or more of these risks or uncertainties materialize or should any of our assumptions prove to be incorrect, our actual results may vary in material respects from what we may have expressed or implied by these forward-looking statements. Any forward-looking statement made by Convey speaks only as of the date on which it is made. All future written and oral forward-looking statements attributable to Convey or persons acting on Convey's behalf are expressly qualified in their entirety by the previous statements. Convey undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by applicable securities laws.

    About the Transaction

    For more information about the transaction, please see the documents filed by Convey with the SEC regarding the transaction, which may be obtained, free of charge, from the SEC's website at www.sec.gov or from Convey's website at https://ir.conveyhealthsolutions.com/financials/sec-filings/default.aspx.

    Contacts

    Convey

    Investor Relations Contact

    Gene Mannheimer

    ICR Westwicke

    [email protected]

    Media Contact

    Tom Pelegrin

    Senior Vice President & Chief Revenue Officer

    [email protected]

    TPG

    Leslie Shribman and Courtney Power

    [email protected]

    415-743-1550

     

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/convey-announces-closing-of-acquisition-by-tpg-301643504.html

    SOURCE Convey Health Solutions

    Get the next $CNVY alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CNVY

    DatePrice TargetRatingAnalyst
    4/7/2022$12.00Buy
    Guggenheim
    2/11/2022$10.00Neutral
    Goldman
    7/12/2021$18.00Buy
    Canaccord Genuity
    7/12/2021$16.00Buy
    Truist Securities
    7/12/2021$21.00Buy
    Goldman
    7/12/2021$15.00Buy
    BofA Securities
    7/12/2021$16.00Overweight
    Barclays
    7/12/2021$12.00Neutral
    JP Morgan
    More analyst ratings

    $CNVY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Convey Announces Closing of Acquisition by TPG

    Convey Taken Private by TPG for $10.50 per Share in Cash FORT LAUDERDALE, Fla., Oct. 7, 2022 /PRNewswire/ -- Convey Health Solutions Holdings, Inc. (NYSE:CNVY) ("Convey"), a leading healthcare technology and services company, announced today the closing of its acquisition by TPG Capital, the large-scale U.S. and European private equity platform of alternative asset management firm TPG. On June 21, 2022, Convey announced that TPG Capital had signed a definitive agreement to acquire all of the outstanding shares of Convey common stock not currently owned by TPG or certain manage

    10/7/22 8:30:00 AM ET
    $CNVY
    Retail: Computer Software & Peripheral Equipment
    Technology

    Convey To Be Taken Private By TPG

    Convey Shareholders to Receive $10.50 per Share in Cash, Representing a 99% Premium Over Convey's 30-Day Volume Weighted Average Price FORT LAUDERDALE, Fla., June 21, 2022 /PRNewswire/ -- Convey Health Solutions Holdings, Inc. (NYSE:CNVY) ("Convey"), a leading healthcare technology and services company, announced today that it has entered into a definitive merger agreement pursuant to which TPG Capital, the private equity platform of global alternative asset management firm TPG ("TPG") and Convey's principal shareholder, will acquire all of the outstanding shares of Convey common stock not currently owned by TPG or certain management and director shareholders for $10.50 per share in cash, re

    6/21/22 7:00:00 AM ET
    $CNVY
    Retail: Computer Software & Peripheral Equipment
    Technology

    Convey Health Solutions Announces Financial Results for First Quarter 2022

    First Quarter 2022 Highlights Net revenues of $96.7 million, up 17% compared to Q1 2021 of $82.6 millionNet loss of $1.2 million, which includes $1.6 million of HealthSmart purchase accounting and acquisition related expenses, compared to Q1 2021 net loss of $0.9 millionAdjusted EBITDA of $15.3 million, compared to Q1 2021 of $15.9 millionFORT LAUDERDALE, Fla., May 10, 2022 /PRNewswire/ -- Convey Health Solutions Holdings, Inc. (NYSE:CNVY) (the "Company" or "Convey"), a leading healthcare technology and services company in the U.S., announced today financial results for the first quarter ended March 31, 2022.

    5/10/22 4:05:00 PM ET
    $CNVY
    Retail: Computer Software & Peripheral Equipment
    Technology

    $CNVY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4: Steele John E. returned $1,915,148 worth of shares to the company (182,395 units at $10.50), decreasing direct ownership by 97% to 5,775 units

    4 - Convey Health Solutions Holdings, Inc. (0001787640) (Issuer)

    10/12/22 7:34:43 PM ET
    $CNVY
    Retail: Computer Software & Peripheral Equipment
    Technology

    SEC Form 4 filed by Mansukani Sharad

    4 - Convey Health Solutions Holdings, Inc. (0001787640) (Issuer)

    10/12/22 7:33:33 PM ET
    $CNVY
    Retail: Computer Software & Peripheral Equipment
    Technology

    SEC Form 4: Whitmer William Carl returned $264,600 worth of shares to the company (25,200 units at $10.50), closing all direct ownership in the company

    4 - Convey Health Solutions Holdings, Inc. (0001787640) (Issuer)

    10/12/22 7:31:54 PM ET
    $CNVY
    Retail: Computer Software & Peripheral Equipment
    Technology

    $CNVY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Guggenheim initiated coverage on Convey Health with a new price target

    Guggenheim initiated coverage of Convey Health with a rating of Buy and set a new price target of $12.00

    4/7/22 7:11:01 AM ET
    $CNVY
    Retail: Computer Software & Peripheral Equipment
    Technology

    Goldman initiated coverage on Convey Health with a new price target

    Goldman initiated coverage of Convey Health with a rating of Neutral and set a new price target of $10.00

    2/11/22 7:13:46 AM ET
    $CNVY
    Retail: Computer Software & Peripheral Equipment
    Technology

    Canaccord Genuity initiated coverage on Convey Health with a new price target

    Canaccord Genuity initiated coverage of Convey Health with a rating of Buy and set a new price target of $18.00

    7/12/21 7:50:21 AM ET
    $CNVY
    Retail: Computer Software & Peripheral Equipment
    Technology

    $CNVY
    SEC Filings

    View All

    SEC Form 15-12G filed by Convey Health Solutions Holdings Inc.

    15-12G - Convey Health Solutions Holdings, Inc. (0001787640) (Filer)

    10/17/22 5:19:00 PM ET
    $CNVY
    Retail: Computer Software & Peripheral Equipment
    Technology

    SEC Form S-8 POS filed by Convey Health Solutions Holdings Inc.

    S-8 POS - Convey Health Solutions Holdings, Inc. (0001787640) (Filer)

    10/7/22 3:52:23 PM ET
    $CNVY
    Retail: Computer Software & Peripheral Equipment
    Technology

    SEC Form S-8 POS filed by Convey Health Solutions Holdings Inc.

    S-8 POS - Convey Health Solutions Holdings, Inc. (0001787640) (Filer)

    10/7/22 3:51:23 PM ET
    $CNVY
    Retail: Computer Software & Peripheral Equipment
    Technology

    $CNVY
    Leadership Updates

    Live Leadership Updates

    View All

    Convey Health Solutions Holdings, Inc. Appoints Paul V. Campanelli to Board of Directors

    FORT LAUDERDALE, Fla., Feb. 15, 2022 /PRNewswire/ -- Convey Health Solutions Holdings, Inc. (NYSE:CNVY) ("Convey"), a leading healthcare technology and services company, today announced the appointment of Paul Campanelli to its Board of Directors ("Board"). Mr. Campanelli has approximately 30 years of experience in the healthcare industry, including leadership positions in both publicly held and private equity controlled companies. Mr. Campanelli previously served as Chairman of the Board of Endo International ("Endo") from November 2019 to June 2021, and previously served as

    2/15/22 4:05:00 PM ET
    $CNVY
    Retail: Computer Software & Peripheral Equipment
    Technology

    $CNVY
    Financials

    Live finance-specific insights

    View All

    Convey Health Solutions Announces Financial Results for First Quarter 2022

    First Quarter 2022 Highlights Net revenues of $96.7 million, up 17% compared to Q1 2021 of $82.6 millionNet loss of $1.2 million, which includes $1.6 million of HealthSmart purchase accounting and acquisition related expenses, compared to Q1 2021 net loss of $0.9 millionAdjusted EBITDA of $15.3 million, compared to Q1 2021 of $15.9 millionFORT LAUDERDALE, Fla., May 10, 2022 /PRNewswire/ -- Convey Health Solutions Holdings, Inc. (NYSE:CNVY) (the "Company" or "Convey"), a leading healthcare technology and services company in the U.S., announced today financial results for the first quarter ended March 31, 2022.

    5/10/22 4:05:00 PM ET
    $CNVY
    Retail: Computer Software & Peripheral Equipment
    Technology

    Convey Health Solutions to Announce First Quarter 2022 Financial Results on May 10, 2022

    FORT LAUDERDALE, Fla., May 3, 2022 /PRNewswire/ -- Convey Health Solutions Holdings, Inc. (NYSE:CNVY) ("Convey Health Solutions" or "Convey"), a leading healthcare technology and services company, announced today that it will issue a press release with first quarter 2022 financial results on Tuesday, May 10, 2022 after the market closes. In conjunction with the release, Convey will host a conference call to review these financial results at 4:30 p.m. (ET) on the same day. First Quarter 2022 Conference Call Details The conference call can be accessed by dialing (844) 200-6205 for U.S. participants, or +1 (929) 526-1599 for international participants, referencing access code 105506; or via a l

    5/3/22 4:17:00 PM ET
    $CNVY
    Retail: Computer Software & Peripheral Equipment
    Technology

    Convey Health Solutions to Announce Fourth Quarter and Full Year 2021 Financial Results and Issue 2022 Guidance on March 23, 2022

    FORT LAUDERDALE, Fla., Feb. 23, 2022 /PRNewswire/ -- Convey Health Solutions Holdings, Inc. (NYSE:CNVY) ("Convey Health Solutions" or "Convey"), a leading healthcare technology and services company, announced today that it will issue a press release with fourth quarter and full year 2021 financial results and 2022 guidance on Wednesday, March 23, 2022 after the market closes. In conjunction with the release, Convey will host a conference call to review these financial results at 5:00 p.m. (ET) on the same day. Fourth Quarter and Full Year 2021 Conference Call Details The confe

    2/23/22 8:00:00 AM ET
    $CNVY
    Retail: Computer Software & Peripheral Equipment
    Technology

    $CNVY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Convey Health Solutions Holdings Inc. (Amendment)

    SC 13G/A - Convey Health Solutions Holdings, Inc. (0001787640) (Subject)

    2/10/23 4:26:13 PM ET
    $CNVY
    Retail: Computer Software & Peripheral Equipment
    Technology